RegeneRx Biopharmaceuticals (RGRX) Short Interest Ratio & Short Volume

Short interest is the volume of RegeneRx Biopharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 100 shares of RGRX short. Learn More on RegeneRx Biopharmaceuticals' current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RGRX shares currently have a short interest ratio of 1.0. Learn More on RegeneRx Biopharmaceuticals's short interest ratio.

Here is how the short interest of companies in the sector of "medical" compare to RegeneRx Biopharmaceuticals: IMV Inc. (1.31%), Context Therapeutics Inc. (0.29%),

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks.

Short selling RGRX is an investing strategy that aims to generate trading profit from RegeneRx Biopharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for RegeneRx Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RGRX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RGRX, twice per month. The most recent reporting period available is April, 15 2024.